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Tissue homeostasis is a dynamic process involving proliferation and the removal of redundant or damaged cells.This is exemplified
in the coordinated deletion—triggered by limiting trophic factors/cytokines in the extracellular milieu—of differentiated T cells
overproduced during the mammalian immune response. However, mechanisms by which extracellular cues are perceived and
transduced as apoptotic triggers remain incompletely understood. T-effectors are dependent on cytokines for survival and undergo
apoptosis following cytokine withdrawal. Here we report that leptomycin B (LMB), an inhibitor of nuclear export machinery,
protected T-effectors from apoptosis implicating a nuclear intermediate in the apoptotic pathway. Evidence is presented that the
linker histone H1.2 localizes to the cytoplasm, by a mechanism sensitive to regulation by LMB, to activate apoptotic signaling
culminating in nuclear and mitochondrial damage in T-effectors in response to cytokine deprivation. H1.2 is detected in a complex
with the proapoptotic mitochondrial resident Bak and its subcellular localization regulated by Jun-N-terminal kinase (JNK), an
intermediate in the apoptotic cascade in T-effectors. These data suggest that metabolic stressors may impinge on H1.2 dynamics
favoring its activity at the mitochondrion, thereby functioning as a molecular switch for T-effector apoptosis.
1. Introduction
Cells divide and differentiate to acquire distinct cell fates in
multicellular organisms. However, differentiation and prolif-
eration are balanced by the programmed deletion of excess
or damaged cells, which is critical for tissue homeostasis.
Core elements of the cellular machinery regulating cell death
are conserved in different phyla [1] and at least two major
pathways regulating apoptosis have been described in mam-
malian cells. Signaling cascades initiated by ligand-receptor
engagements of the TNFR (tumor necrosis factor receptor)
superfamily constitute the extrinsic pathway [2].The intrinsic
pathway is activated by metabolic and genotoxic stressors
and integrated at the mitochondrion, with members of the
Bcl-2 family, which comprise both pro- and antiapoptotic
members emerging as dominant regulators of these responses
[1, 3, 4]. Cross talk between these two pathways is well docu-
mented. Cell-death pathways are variously deployed during
development and in adult tissues as seen in the nervous,
reproductive, and immune system where cells are overpro-
duced and then removed by apoptosis [5–9]. Competition
for limiting nutrients in the extracellular milieu is a widely
prevalent mechanism for the regulation of cell number [10–
12]. However, mechanisms by which cells perceive changes in
their microenvironment are not fully understood.
In this study, we sought to address this question in a well-
characterized model system that recapitulates the deletion of
differentiated T cells in cell culture. The mature T cell com-
partment is characterized by dramatic increase in cell number
in response to antigen challenge, followed by the eventual
elimination of antigen-reactive T-effector cells so generated,
a cycle repeated throughout adult life and necessary for
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immune functionality [13, 14]. T-effectors generated in the
immune response depend on cytokines or trophic factors for
nutrient uptake and experiments in vitro and in vivo model
systems indicate that the apoptotic response to nutrient dep-
rivation is mediated by reactive oxygen species- (ROS-)
dependent signaling that converges on the mitochondrion
[15–18]. While T-cell dependence on cytokines and the ROS-
Bcl-2 family signaling axis for survival and apoptosis, respec-
tively, is well established, the cellular machinery that senses
and integrates changes in the extracellular milieu remains
uncharacterized and forms the focus of this study.
A critical role for nuclear effectors in initiating apoptotic
signaling in T-effectors was indicated in our experiments
since blocking nuclear export machinery protected cells from
apoptosis. Building on a previously described role for the
linker histone H1.2 in propagation of apoptotic cascades we
followed the spatial dynamics of the linker histone H1.2 iso-
form in T-effectors. Our experiments show that the nuclear
export machinery and JNK activity regulate H1.2 translo-
cation and activity in T-effectors undergoing apoptosis. We
provide evidence of H1.2 interaction with the Bcl-2 family
proapoptotic protein Bak and propose that H1.2 converges on
apoptotic signaling cascades integrated at themitochondrion.
Its role in apoptosis is indicated by the abrogation of apoptotic
damage in response to cytokine deprivation following H1.2
ablation in T-effectors. Finally, our experiments implicate the
Jun-N-terminal kinase (JNK) in regulating H1.2 dynamics,
suggesting a more expansive role for this signaling cascade
in tissue homeostasis.
2. Materials and Methods
2.1. Mice. C57BL/6 mice were obtained from The Jack-
son Laboratory (Maine, USA) and maintained at the Ani-
mal Facility at the National Centre for Biological Sciences
(NCBS), Bangalore, India. Manipulations involving animals
were approved by the Institutional Animal Ethics Commit-
tees of NCBS, Bangalore, India, and followed norms specified
by theCommittee for the Purpose of Control and Supervision
of Experiments on Animals (CPCSEA), Government of
India.
2.2. Reagents. Antibodies were used at dilutions indicated
and procured from the following sources: H1 (1 : 1000) and
p38MAPK (1 : 1000) from Santa Cruz (Santa Cruz, CA); AIF
(1 : 500) from Chemicon (Billerica, MA); H1.2 (1 : 1000) from
Proteintech Europe (Manchester, UK); H3 (1 : 500), H3Ac
(1 : 500), and HP1𝛼 (1 : 1000) from Upstate Biotechnology
(Lake Placid, NY); 𝛼-actin (1 : 500) and 𝛼-tubulin (1 : 250)
from Neomarker (Fremont, CA); and Bak (1 : 1000), Cox-IV
(1 : 250), and p-JNK/SAPK (1 : 500) fromCell Signaling Tech-
nology (Beverly, MA). The shRNA plasmids to H1.2 and the
scrambled control were from Origene Technologies (Rock-
ville, MD). TMRM (tetramethyl rhodamine methyl ester)
was obtained from Sigma (St. Louis); Annexin-VAlexaFluor-
488 was from Invitrogen (Carlsbad, USA); anacardic acid,
leptomycin B, and SP600125 were from Calbiochem (San
Diego, CA).
2.3. Generation of T-Effectors. T-cells were isolated from
spleens of 6–8-week-old C57BL/6 mice, using mouse IgG
coated magnetic (GAMT) beads (NEB, USA) or using CD3+
T cell isolation kits (R&D Systems). T-effectors were gener-
ated as described [17]. Briefly, T-cells were stimulated using𝛼-
CD3/𝛼-CD28 bound beads (Invitrogen) at 2.0 × 106 cells/mL
or in some instances soluble anti-CD3 (500 ng/mL, clone
2C11; R&D Systems) at 2.5 × 106 T cells/mL in cultures spiked
with 104 splenic adherent cells. T-effectors generated after
48 hours were used for assays or continued in culture with
1 𝜇g/mL cytokine interleukin-2 (R&D Systems) for 24–36
hours. Activation was established by expression of CD69 and
CD25 along with the changes in morphology and increased
size of T-cells [19].
2.4. Assays of Apoptosis. Assays of cytokine deprivation were
performed as described [17]. 0.4 × 106/mL T-effectors were
washed thrice in excess medium and phosphate buffered
saline (PBS) to remove bound cytokine and then continued
in culture with or without IL-7. Apoptosis was assayed at
different time points after cytokine deprivation as indicated
in the experiments. For assays of subcellular fractionation,
cells were typically harvested at 6 hours for the analysis of
H1.2 dynamics and at a delayed time point of 8 hours to
examine the translocation of AIF. In experiments where H1.2
andAIF translocationswere examined together, sampleswere
harvested at the earlier time point of 6 hours.
To assess apoptotic nuclear damage, cells were stained
for 3 minutes with the Hoechst-33342 (1𝜇g/mL) at ambient
temperature and nuclear morphology scored in a minimum
of 200 cells in each sample, using a fluorescence microscope
equipped with a UV filter. For staining with Annexin-V, 0.3 ×
106 T-effectors were incubated with Annexin-V (1 : 60/106
cells) for 15min at room temperature, washed once with PBS,
and analyzed immediately by flow cytometry following the
addition of propidium iodide. For the assessment of mito-
chondrial transmembrane potential, cells were incubated
with a 50 nMmitochondria-specific dye, TMRM, in medium
for 15 minutes at 37∘C, followed by two gentle washes with
PBS and immediately analyzed by flow cytometry.
2.5. Retroviral Infections. For packaging murine retroviruses
with shRNA plasmids, 1𝜇g of DNA was cotransfected with
1 𝜇g of pClEco (packaging vector) in HEK293T cells. After 48
hours, the culture supernatant was concentrated and used for
infecting T-cells by previously described protocols [17, 20].
Infected T cells were maintained in RPMI complete medium
supplemented with 1𝜇g/mL IL-2, 2 ng/mL IL-7, and 1 𝜇g/mL
puromycin for 3 days. Live cells were isolated using Ficoll and
continued in culture with IL-2 for 24 hours before being used
in cytokine deprivation assays. Protein levels were assessed by
Western blot analysis.
2.6. Western Blot Analysis. 0.3–0.5 × 106 cells were lysed in a
SDS lysis buffer (2% SDS, glycerol, bromophenol blue), 1M
DTT, and 1M Tris—HCl pH 6.8 supplemented with a pro-
tease inhibitor cocktail—aprotinin, leupeptin, and pepstatin
(2 𝜇g/mL each), 1mM PMSF, 1mM NaF, and 1mM Na
3
VO
4
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for 10 minutes at 100∘C. Using previously established proto-
cols [17, 20], whole cell lysates were resolved by SDS-PAGE
and transferred to nitrocellulose membrane (GE Healthcare)
and incubated overnight at 4∘C with primary antibodies at
concentrations recommended by the manufacturers. Mem-
brane was washed thrice with TBS-Tween20 followed by
HRP-conjugated secondary antibody (CST, 1 : 1000 dilution)
for 1 hour at RT. Membranes were developed either by
exposing to X-ray film using an Amersham Hyperprocessor
or an ImageQuant LAS 4000 Biomolecular Imager (GE
Healthcare).
2.7. Subcellular Fractionation. 10 × 106 T-effectors were used
for the subcellular fractionation protocol [21]. Cytoplasmic
and nuclear fractions were obtained using the NE-PER
nuclear and cytoplasmic extraction kit (Thermo Scientific)
followingmanufacturer’s instructions. Equivalent volumes of
nuclear and cytoplasmic fractions were boiled in SDS lysis
buffer for Western blot analysis.
2.8. Immunoprecipitation. 10 × 106 T-effectors cultured in the
absence of cytokine were lysed for 1 hour at 4∘C in 1%CHAPS
lysis buffer supplemented with protease inhibitors (2𝜇g/mL
aprotinin, leupeptin, pepstatin, 1mM PMSF, 1mM NaF, and
1mM Na
3
VO
4
). 10 𝜇L antibody was used for precipitating
immune complex for 2 hours at 4∘C using protein G agarose
beads (Pierce Biotechnology) on a rotator. Beadswerewashed
five times with ice-cold PBS at 1700 rpm and then boiled
in SDS lysis buffer for 10min for the Western blot analysis.
When the cytoplasmic fraction was used as an input for the
IP, 20 × 106 T-cells were subjected to subcellular fractionation
as described above and the cytoplasmic fraction obtainedwas
used for immunoprecipitation. True-blot HRP (Ebioscience)
has been used for immunoblots of Bak and H1.2.
2.9. Statistical Methods. All graphs show data presented as
mean ± SD from a minimum of three independent exper-
iments. Statistical significance was calculated using the two
population Student’s 𝑡-tests, with the following confidence
intervals: ∗99% and ∗∗99.9%.
3. Results
3.1. Apoptosis in T-Effectors Is Regulated by Nuclear Events. T-
cells proliferate and differentiate in response to antigen, to
generate lineage-committed effectors, the bulk of which die,
marking termination of the immune response [14]. Key ele-
ments of this process can be recapitulated in vitro, permitting
investigations into the molecular regulation of T-cell apopto-
sis [16–18, 20, 21]. Using this experimental system we show
that cytokine withdrawal from T-effectors triggers apoptotic
damage characterized by nuclear fragmentation and exter-
nalization of phosphatidylserine (PS) at the cell membrane
(Figures 1(a) and 1(b)). Loss of mitochondrial integrity is
another feature of cells undergoing apoptotic duress and
is reflected in the spatial redistribution of the flavoprotein,
AIF (apoptosis inducing factor) [22]. AIF is a mitochondrial
intermembrane space resident protein, which is released from
mitochondria as a consequence of loss of outer mitochon-
drial membrane integrity and translocates to the nucleus to
mediate DNA damage [21, 23]. In T-cells cultured in cytokine
assessed prior to the onset of the deprivation protocol (T0),
AIF is detected in the cytoplasmic fraction consistent with its
localization to mitochondria (Figure 1(c)). Subcellular frac-
tionation of T-cells following cytokine withdrawal indicated
that a substantial signal for AIF is detected in the nuclear
fraction (Figure 1(d)). In these assays, we also probed for the
distribution of the nuclear heterochromatin binding protein
Hp1𝛼 and the mitochondrial matrix resident Cox-IV to
establish purity of the fractions (Figures 1(c)–1(e)).
Leptomycin B (LMB), a Crm1 inhibitor that blocks
nuclear export, substantially reduced apoptotic damage in
T-effectors (Figures 1(a) and 1(b)), implicating a nuclear
intermediate in the cascade. LMB is typically used at con-
centrations that range from 0.3 to 10 ng/mL although lower
concentrations are also effective at blocking nuclear export
[24]. Since 0.3 ng/mL LMB was toxic to T-cells in culture, we
tested lower concentrations and found that 0.03mg/mL or
0.003 ng/mL LMB was well tolerated by T-effectors cultured
with cytokine. Since both concentrations also protected from
apoptosis with comparable efficacy (not shown), the experi-
ments using the lower concentrations of LMB have been used
in the current study. The distribution of AIF in cells cultured
without cytokine but in the presence of LMB (Figure 1(e)) was
restored to the pattern of live cells (Figure 1(c)), indicating
that LMB prevented damage to the mitochondrial outer
membrane, a necessary step for the release of AIF. These
observations suggested that events in the nucleus influence
early, premitochondrial steps of the apoptotic cascade. The
linker histone H1.2 has been shown to initiate apoptotic
cascades integrated by the mitochondrion, first reported in
the context of the DNA damage response in immature T-
cells [25]. Activation of H1.2 dependent apoptotic signaling is
associated with its displacement from the nucleus. Hence, in
subsequent experiments we assessed the cellular distribution
and possible involvement of H1.2 in T-effector apoptosis.
3.2. Changes in H1.2 Localization in T-Effectors Undergoing
Apoptosis. H1.2 is typically detected in the nucleus
as evidenced in the analysis of nuclear and cytoplasmic
fractions of cells cultured in conditions that promote
survival (Figure 2(a)). In contrast to this distribution,
subcellular fractionation of cells following cytokine
withdrawal (within 6 hours of the deprivation protocol)
was characterized by the appearance of cytoplasmic pools of
H1.2 (Figure 2(b)). This positions the translocation of H1.2
at a relatively early time-point in the apoptotic process, well
before overt evidence of nuclear damage in experimental
conditions. The distribution of the mitochondrial resident
protein Cox-IV and the nuclear protein HP1𝛼 established
purity of the cytoplasmic and nuclear fractions, respectively,
in these assays. Consistent with the inhibition of apoptotic
nuclear damage, if LMBwas included in cytokine-withdrawal
conditions, the distribution of H1.2 was restored to the
pattern of live cells and only detected in the nucleus
(Figure 2(c)). To assess the functional implications of the
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Figure 1: LMB blocks cytokine deprivation induced apoptotic damage in T-effectors. (a)-(b) 0.3 × 106 T-effectors were cultured with or
without IL-7 (20 ng/ml) with the addition of vehicle control or LMB (0.003 ng/ml). Apoptotic nuclear damage (a) and Annexin-V binding (b)
were scored after 8 and 15 hours, respectively. The dotted lines in (b) indicate cells continued in cytokine. The graph shows mean ± SD from
4 experiments. ∗∗𝑃 < 0.001. (c)–(e) 10 × 106 T-effectors were cultured in the indicated conditions (T0: freshly activated) and 8 hours later
cells were fractionated as described in Materials and Methods. Immunoblots of nuclear and cytoplasmic fractions obtained were probed for
AIF, HP1𝛼, and Cox-IV. Data are representative of three independent trials.
change in H1.2 localization and elucidate its role, if any, in
apoptosis, RNA interference approaches were employed to
ablate H1.2 function in T-effectors.
T-effectors were transduced using retroviruses with
shRNA to H1.2 or a scrambled control and cultured in puro-
mycin containing medium, as described in materials and
Methods, in order to enrich for transfected cells [17]. Efficacy
of the shRNA for depletion of H1.2 was established in
the NIH3T3 fibroblast cell line (not shown) and as shown
demonstrably reduced protein expression in T-effectors
(Figure 2(d), inset). T-effectors treated with scrambled or
H1.2 shRNA were assessed for their response to cytokine
deprivation in the experiments that follow. In contrast to
cells transduced with scrambled shRNA, cells with reduced
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Figure 2: H1.2 is an intermediate in the apoptotic cascade triggered by cytokine deprivation. (a)–(c) 10× 106 T-effectors were cultured in the
indicated conditions (T0: freshly activated) and 6 hours later subject to subcellular fractionation. Immunoblots of nuclear and cytoplasmic
fractions were probed for H1.2, HP1𝛼, Bak, or Cox-IV. Data are representative of three independent trials. (d)-(e) T-effectors transduced
using retrovirus expressing scrambled control or histone H1.2 shRNA, as described in Materials and Methods, were cultured with or without
cytokine for 10 hours. Cells were scored for apoptotic nuclear damage using Hoechst-33342 (d) or mitochondrial transmembrane potential
using TMRM (e) as described in Materials and Methods. Graphs show mean ± SD from 5 experiments in (d) and 2 experiments in (e),
normalized to cultures with cytokine. Inset: Immunoblot for H1.2 protein and tubulin (parity in loading) in shRNA expressing T-effectors.
∗
𝑃 < 0.01.
H1.2 protein levels were protected from nuclear damage
triggered by cytokine deprivation (Figure 2(d)). In order
to assess if loss of H1.2 also protected from mitochondrial
damage we used flow cytometry based analysis of intact cells.
Loss of mitochondrial transmembrane potential is a sensitive
indicator of damage to the organelle and characteristic of
cells undergoing apoptosis. Hence we tested if H1.2 ablation
protected T-effectors from mitochondrial damage triggered
by cytokine deprivation. In these experiments, changes in
mitochondrial activity were assessed by the uptake of the
potentiometric dye TMRM. In contrast to cells expressing the
control, scrambled shRNA, TMRM intensity was comparable
in the presence or absence of cytokine in cells with an ablation
of H1.2 consistent with protection from death (Figure 2(e)).
This strongly suggests that reduced H1.2 levels protected cells
from damage to mitochondria otherwise observed in cells
in conditions of cytokine withdrawal. We did not observe
deleterious effects of H1.2 depletion in T-effectors continued
in culture in cytokine, indicating a specific role for H1.2
in the response to apoptotic stimuli. These data positioned
H1.2 translocation and activity at a step controlling events
culminating in compromised mitochondrial function and
nuclear integrity in the apoptotic cascades in T-effectors.
3.3. H1.2 Associates with Bak in T-Effectors. H1.2 has been
reported to localize to the mitochondrion and participate
in apoptotic cascades involving the mitochondrial resident
protein Bak [25, 26]. The experiments described in the
preceding sections indicated that H1.2 activity converged on
6 International Journal of Cell Biology
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Figure 3: H1.2 immunoprecipitates with the mitochondrial outer-membrane resident Bak in T-effectors. (a)-(b) 10 × 106 T-effectors were
cultured without cytokine and 6 hours later immunoprecipitated (IP) with an antibody to Bak. Immunoblots of whole cell lysates (WCL) or
the IP were probed with an antibody to H1.2 (a) or a pan H1 antibody (b) and 𝛼-Tubulin. (c) Reverse IP with an antibody to H1 in T-effectors
cultured as described in (a)-(b) and the immunoblot probed for Bak. Actin is the specificity control. (d) 10 × 106 T-effectors were cultured
without cytokine for 6 hours and the cytoplasmic fraction obtained by subcellular fractionation as described in Materials and Methods was
used as input for an IP with an antibody to Bak. A representative immunoblot for H1 in the complex IP is shown. 𝛼-Tubulin is the specificity
control.
mitochondrial function. Hence, we next tested for interac-
tions between Bak and H1.2 in T-effectors under cytokine
deprivation. The immune-precipitation (IP) of these pro-
teins as a complex is evidence of a physical association
(Figure 3(a)), which was confirmed using antibodies that
recognize the H1 family of proteins or with an antibody
specific to H1.2 (Figures 3(a) and 3(b)). Although the lysates
used as the input for IP analysis are a postnuclear supernatant,
we confirmed that core histone H3 was not detected in the
immunoprecipitated complex (IP) indicating that nuclear
pools ofH1.2 were unlikely to be detected in the immunoblots
(Figure 3(a)). Mindful of the detergent sensitivities of Bcl-
2 family proteins [27], these experiments used the milder
detergent CHAPS to generate cell lysates to assess these
interactions. The association between Bak and H1.2 in T-
cells was also confirmed by reverse immunoprecipitation
(Figure 3(c)). In order to rule out possible contamination
of the immunoprecipitated complex with nuclear proteins,
the cytoplasmic fraction of T-effectors in deprivation (purity
ascertained by the exclusion of the nuclear protein HP1𝛼)
was used to immunoprecipitate Bak. H1.2 immunoprecip-
itated in the complex with Bak when the cytoplasmic
fraction was used as input as well, confirming that the
association is occurring outside the nucleus (Figure 3(d)).
The experiments thus far implicate H1.2 as key intermediate
in the apoptotic response of T-effectors. In previous work
[17], hierarchical interactions involving the Jun-N-terminal
kinase (JNK) have been demonstrated to regulate T-effector
apoptosis. Therefore, in the experiments that follow we
attempted to position H1.2 activity in the context of known
premitochondrial intermediates in the apoptotic cascade in
T-effectors.
3.4. JNK Activity Regulates H1.2 Dynamics in T-Effectors.
ROS-dependent activation of the JNK regulates deprivation-
induced apoptosis in T-effectors and apoptotic cascades in
other cell types [17, 28]. Hence we asked if JNK inhibited
the translocation of H1.2 in T-effectors. To modulate JNK
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Figure 4: JNK regulates H1.2 displacement in T-effectors. (a) Representative immunoblot of nuclear and cytoplasmic fractions of T-effectors
cultured without cytokine +100 nM SP600125 for 6 hours. The immunoblots were probed with antibodies to H1.2, HP1𝛼, and Cox-IV and
controlled with fractions generated in previous experiments. Data shown is representative of two independent trials. (b) Representative
immunoblot for phosphorylated JNK in T-effectors cultured as described in (a). p38MAPK is the loading control. (c) Apoptotic nuclear
damage in T-effectors cultured with and without cytokine (IL-7) in the presence or absence of vehicle control or 100 nM SP600125 for 24
hours. The graph shows the mean ± SD from 3 experiments. ∗∗𝑃 < 0.001.
activity we used the inhibitor, SP610025, demonstrated in
earlier experiments to regulate JNK activity in T-effectors
[17]. In the analysis of nuclear and cytoplasmic fractions, in
cultures where SP610025 was added at the onset of the depri-
vation protocol, the distribution of H1.2 was comparable
to control cells and detected only in the nuclear fraction
(Figure 4(a)). Confirming earlier reports and consistent with
its effect on the subcellular localization of H1.2, blocking JNK
(Figure 4(b)) also protected T-cells from apoptotic damage
(Figure 4(c)). Growing evidence of cross talk between signal
transduction pathways and the metabolic status of cells,
wherein evidence that metabolic stress triggers changes
in acetylation and consequently mitochondrial function
[29–31], prompted us to assess possible regulation of T-
effector apoptosis by cellular acetylation machinery.
3.5. Acetylation Dependence of T-Effector Apoptosis. Mount-
ing evidence of proteins modified by acetylation outside of
conventional chromatin targets suggest a broader array and
range of cellular processes regulated by thismodification [32–
34]. As a first approximation, a possible role of acetylation
in the activation of the H1.2 mediated apoptotic cascade
in T-effectors was tested. Anacardic acid (AA), a broad-
spectrum inhibitor of lysine acetyl-transferases protected T-
cells from apoptotic damage as seen in assays of nuclear
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Figure 5: Acetylation dependence of the sub-cellular localization of H1.2 and apoptosis in T-effectors. (a) Apoptotic nuclear damage in T-
effectors cultured without cytokine IL-7 (20 ng/ml) and with or without anacardic acid (AA) (20𝜇M) for indicated time points. The graph
shows the mean ± SD from three experiments. Inset: immunoblot for acetylated H3 (H3Ac) and 𝛼-tubulin in T-effectors cultured without
cytokine (for 6 hours) in the presence or absence of AA. (b) T-effectors cultured for 18 hours in the indicated conditions were stained with
propidium iodide (𝑥-axis) and Annexin-V (𝑦-axis) analyzed by flow cytometry. Values in the upper right quadrant, in each plot, indicate dead
cells. (c) 10 × 106 T-effectors were cultured without cytokine IL-7 (20 ng/ml) and with or without AA (20𝜇M) for 6 hours. Immunoblots of
nuclear and cytoplasmic fractions were probed for H1 or H1.2, HP1𝛼, and AIF. Data shown is representative of three independent trials.
morphology (Figure 5(a)). To assess if AA delayed rather
than inhibited cell death, the uptake of propidium iodide
(PI) was also measured in these conditions. After 18 hours in
culture without cytokine, the coincident staining with PI and
Annexin-V indicated the occurrence of membrane damage,
which is in contrast to cells cultured in cytokine (Figure 5(b)).
In cells that were cultured with AA, PI and Annexin-V
staining was comparable (and low), indicating that AA pre-
vented the loss of membrane integrity (Figure 5(b)). Further,
the translocation of H1.2 (and AIF) was inhibited in cells
treated with AA relative to the group cultured without
cytokine (Figure 5(c)), supporting a possible role for changes
in acetylation states as a regulatory step in the apoptotic
response in T-effectors. The molecular target(s) of this
modification remains to be identified. Experiments discrim-
inating between the possibilities that H1.2 displacement may
be a response to acetylation-dependent changes of chromatin
organization vis-a`-vis effects on histones or by the modula-
tion of nonhistone proteins would provide additional insight
into this regulation.
4. Discussion
Competition for limiting nutrients in the extracellular milieu
is a widely prevalent mechanism for the regulation of cell
number and mechanisms by which cells perceive these
changes in their microenvironment continue to be actively
investigated. Reduced availability of cell extrinsic growth
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factors frequently underlies the coordinated deletion of cells
overproduced during development or differentiation. We
address this question in a model system that recapitulates the
deletion (induced by cytokine withdrawal) of differentiated
T-cells in cell culture. We provide evidence that the nucleus
functions as a site for integration of extracellular nutritional
cueswith significant consequences to T-cell survival.Thiswas
indicated in the experiments wherein LMB blocked apoptotic
damage in T-effectors in response to cytokine deprivation
implicating a nuclear intermediate in the signaling cascade.
Involvement of nuclear events was confirmed in experiments
where, following cytokine withdrawal, we observed that
H1.2 was displaced from the nucleus to translocate to the
mitochondrion, initiating cascades culminating in cell death.
H1.2 translocation from the nucleus has been previously
reported in immature thymocytes and chronic lymphocytic
leukemic cells in response to genotoxic and nongenotoxic
drug treatment [25, 26, 35]. In support of this, we present
evidence for H1.2 interactions with the mitochondrial outer-
membrane resident, the proapoptotic protein Bak, and its
regulation of ensuing damage to mitochondria and the
nucleus in T-effectors undergoing apoptosis.These data open
up possibilities—not mutually exclusive—of H1.2 associated
molecules that regulate apoptotic outcomes or, modifications
to H1.2 itself that may be necessary for its activity at the
mitochondrion.
A hierarchy of interactions involving Bcl-2 family pro-
teins (Bax and Bak amongst others) and reactive oxygen
species are implicated in the apoptotic deletion of T-cells [3,
13–15, 17, 18]. Current understanding of apoptotic signaling
positionedmoleculeswithwell-characterized functions at the
mitochondrion as key intermediates in T-cell apoptosis. Since
ablation of H1.2 protected cells from apoptosis in culture,
the data suggests an intriguing possibility of amplification
or reinforcing loop mediated by H1.2, which converges on
the mitochondrion to propagate the apoptotic cascade. We
speculated that if signaling resulting from H1.2 and ROS
activation converges on a single event/organelle, common
regulatory processes might be expected. Earlier work from
the laboratory had shown that Jun-N-terminal kinase (JNK)
was activated by NADPH-mediated ROS production and
regulated mitochondrial damage in the apoptotic response of
T-effectors [17]. Supporting the possibility of a hierarchy of
interactions, JNK activity controlled the subcellular distribu-
tion of H1.2, that is, its liberation from the nucleus following
growth factor deprivation.The underlyingmolecular features
and consequences of H1.2 association with Bak remain to
be elucidated. Based on the observations in this study we
speculate that chromatin may execute a nontranscriptional
response to JNK activity to initiate the observed nonnuclear
functions of H1.2. This outcome may be linked to the
modulation of epigenetic states by JNK activity, which has
precedence in other systems [36–38].
The protective effect of AA is consistent with a role for
acetylation in the regulation of H1.2 relocation and conse-
quent apoptosis.The possibility that lysine acetyl-transferases
form an instructive element in the apoptotic H1.2-dependent
cascade suggested by these observations, however, requires
more detailed analysis. Our attempts to track T-cell con-
traction following antigen challenge in mice injected with
AA were unsuccessful because of the inhibitory effects of
AA on T-cell activation responses in vivo (not shown).
Genetic manipulations of H1.2 levels in T-cell populations
are underway to directly envisage the role of H1.2 pathway
in promoting survival of T effectors in vivo.
Taken together, the experiments suggest that cytokine
inputs necessary for nutrient uptake and consequently sur-
vival in T-effectors are integrated in the nucleus. These
observations position H1.2 in the molecular coupling of
genomic integrity andmitochondrial function, demonstrated
here in the programmed deletion of T-effectors. It is tempting
to speculate that, since cellular responses to metabolic stres-
sors are conserved across cell types, the pathway described
here is likely activated in other cellular contexts involving
homeostasis of differentiated cells.
5. Conclusions
Competition for limiting nutrients in the extracellular milieu
is a ubiquitous mechanism for the regulation of cell number.
Intracellular signaling networks constituting the cellular
response to these changes remain an active area of investi-
gation. In this study we provide evidence that events in the
nucleus integrate extracellular nutritional cues in T-effector
populations and these events are intricately connected to the
apoptotic response elicited by nutritional deprivation. Specif-
ically, in response to cytokine withdrawal the linker histone
H1.2 is displaced from the nucleus to translocate to the
mitochondrion and associatewith themitochondrial resident
protein Bak to trigger T-effector apoptosis. Finally, H1.2
dynamics are regulated by JNK signaling and responsive to
changes in the acetylation status in T-cells.
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